Search research articles
Contact Us
Filters
Showing results (41-50 of 164) with videos related to
Page
of 17
Sort By:
British Journal of Haematology
|
June 13, 2002
T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome
Danièle Bensoussan, Françoise Le Deist, Véronique Latger-Cannard, et al.
Annals of Hematology
|
July 30, 2025
Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS)
Anne Quinquenel, Stéphane Leprêtre, Marie Sarah Dilhuydy, et al.
Stem Cells and Development
|
November 25, 2005
Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro
Pierre Feugier, Na Li, Deog-Yeon Jo, et al.
Leukemia & Lymphoma
|
March 1, 2018
Management of relapsed or refractory follicular lymphoma patients in daily practice - a French non-interventional study
Pierre Feugier, Pauline Brice, Marc Maynadié, et al.
American Journal of Hematology
|
March 2, 2017
BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab
Sarah Huet, Edith Szafer-Glusman, Bruno Tesson, et al.
British Journal of Haematology
|
April 24, 2023
Age-related immune cell dynamics influence outcomes after allogeneic haematopoietic cell transplantation
Alizée Jandin, Cécile Pochon, Arnaud Campidelli, et al.
Blood
|
September 13, 2003
Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia
Olivier Tournilhac, Bruno Cazin, Stéphane Leprètre, et al.
The Lancet. Haematology
|
September 3, 2018
Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study
Hervé Tilly, Franck Morschhauser, Olivier Casasnovas, et al.
American Journal of Hematology
|
March 11, 2015
Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: the French intergroup experience
Luc-Matthieu Fornecker, Thérèse Aurran-Schleinitz, Anne-Sophie Michallet, et al.
Human Pathology
|
August 24, 2014
Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis
Luc Xerri, Emmanuel Bachy, Bettina Fabiani, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 164) with videos related to
Sort By:
Page
of 17
British Journal of Haematology
|
June 13, 2002
T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome
Danièle Bensoussan, Françoise Le Deist, Véronique Latger-Cannard, et al.
Annals of Hematology
|
July 30, 2025
Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS)
Anne Quinquenel, Stéphane Leprêtre, Marie Sarah Dilhuydy, et al.
Stem Cells and Development
|
November 25, 2005
Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro
Pierre Feugier, Na Li, Deog-Yeon Jo, et al.
Leukemia & Lymphoma
|
March 1, 2018
Management of relapsed or refractory follicular lymphoma patients in daily practice - a French non-interventional study
Pierre Feugier, Pauline Brice, Marc Maynadié, et al.
American Journal of Hematology
|
March 2, 2017
BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab
Sarah Huet, Edith Szafer-Glusman, Bruno Tesson, et al.
British Journal of Haematology
|
April 24, 2023
Age-related immune cell dynamics influence outcomes after allogeneic haematopoietic cell transplantation
Alizée Jandin, Cécile Pochon, Arnaud Campidelli, et al.
Blood
|
September 13, 2003
Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia
Olivier Tournilhac, Bruno Cazin, Stéphane Leprètre, et al.
The Lancet. Haematology
|
September 3, 2018
Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study
Hervé Tilly, Franck Morschhauser, Olivier Casasnovas, et al.
American Journal of Hematology
|
March 11, 2015
Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: the French intergroup experience
Luc-Matthieu Fornecker, Thérèse Aurran-Schleinitz, Anne-Sophie Michallet, et al.
Human Pathology
|
August 24, 2014
Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis
Luc Xerri, Emmanuel Bachy, Bettina Fabiani, et al.
Page
of 17